March Altus Capital Management as of March 31, 2016
Portfolio Holdings for March Altus Capital Management
March Altus Capital Management holds 9 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 20.0 | $1.9M | 27k | 72.03 | |
| Edwards Lifesciences (EW) | 15.9 | $1.5M | 17k | 88.23 | |
| Dex (DXCM) | 13.4 | $1.3M | 19k | 67.89 | |
| Aratana Therapeutics | 12.5 | $1.2M | 219k | 5.52 | |
| Alexion Pharmaceuticals | 12.4 | $1.2M | 8.6k | 139.20 | |
| Regeneron Pharmaceuticals (REGN) | 8.6 | $826k | 2.3k | 360.54 | |
| athenahealth | 7.0 | $680k | 4.9k | 138.78 | |
| ACADIA Pharmaceuticals (ACAD) | 6.2 | $603k | 22k | 27.98 | |
| Align Technology (ALGN) | 4.0 | $390k | 5.4k | 72.68 |
